中廣核技(000881.SZ):在綿陽市投建核醫療產業基地預計2024年建成投產
格隆匯6月26日丨有投資者向中廣核技(000881.SZ)提問,“1.你公司為何辦啥事都如此緩慢?2.核環保和普通環保有何區別?具體説下3.醫療科技集團今年就有產出?還是明年有產出?4.公式下醫療集團高管履歷,讓各位股東看看”
中廣核技回覆稱,公司“核環保”指的是電子束處理技術應用於環保產業,電子束處理主要是通過輻射電離作用以及電子束激發水分子產生活性粒子產生氧化-還原反應對污染物進行處理。公司電子束治污技術在難降解工業廢水處理、工業廢水深度處理、污染物無害化處理等領域有明顯優勢,目前正在推進電子束治污技術在印染廢水、製藥廢水、垃圾滲濾液、煤化工廢水、石油化工廢水、醫療廢水、抗生素菌渣無害化處理等領域的商業化應用。公司在綿陽市投資建設核醫療產業基地預計2024年建成投產,同時公司下屬醫療科技公司已同步開展質子治療系統銷售工作,截至目前已簽署三台銷售合同。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.